354
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

COPD: Magnesium in the Plasma and Polymorphonuclear Cells of Patients During a Stable Phase

, , , , , & show all
Pages 41-47 | Published online: 02 Jul 2009

REFERENCES

  • Britton J, Pavord I, Richards K, Wisniewski A, Knox A, Lewis S, Tattersfield A, Weiss S. Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample. Lancet 1994; 344: 357–362
  • Rolla G, Bucca C. Hypomagnesaemia and bronchial hyperreactivity. A case report. Allergy 1989; 44: 519–521
  • Schroll A. Importance of magnesium for electrolyte homeostasis—An overview. Advances in Magnesium Research 1: Magnesium in Cardiology, R Smetana. John Libbey, Vienna 1995; 463–472
  • Hasebe N. Oxidative stress and magnesium. Clin Calcium 2005; 15(2)194–202
  • Crapo R O, Jensen R L, Hargrave F E. Airway inflammation in COPD: physiological outcome measures and induced sputum. Eur Respir J 2003; 21: 19–28
  • Agusto A GN, Noguera A, Salueda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21: 347–360
  • Tam M, Gomez S, Gonzales-Gross M, Marcos A. Possible roles of magnesium on the immune system. Eur J Clin Nutr 2003; 57(10)1193–1197
  • Malpuech-Brugere C, Rock E, Astier C, Nowacki W, Mazur A, Rayssiguier Y. Exacerbated immune stress response during experimental magnesium deficiency results from abnormal cell calcium homeostasis. Life Sci 1998; 63: 1815–1821
  • Bussiere F I, Gueux E, Rock E, Mazur A, Rayssiguier Y. Protective effect of calcium deficiency on the inflammatory response in magnesium-deficient rats. Eur J Nutr 2002; 41: 197–202
  • Bussiere F I, Gueux E, Rock E, Girardeau J P, Tridon A, Mazur A. Increased phagocytosis and production of reactive oxygen species by neutrophil during magnesium deficiency in rats and inhibition by high magnesium concentration. Br J Nutr 2002; 87(2)107–113
  • Rayssiguer Y, Mazur A. Magnesium and inflamation: Lessons from animal models. Clin Calcium 2005; 15(2)245–248
  • Mazur A, Maier J A, Rock E, Gueux E, Nowacki W, Rayssiguier Y. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys. Apr 19, 2006, in press
  • Patel T, Bronk S F, Gores G J. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 1994; 94(6)2183–2192
  • Skotnicki A B, Jablonski M J, Musial J, Swadzba J. The role of magnesium in the pathogenesis and therapy of bronchial asthma. Przegl Lek 1997; 54(9)630–633
  • Emelyanov A, Fedoseev G, Barnes P J. Reduced intracellular magnesium concentration in asthmatic patients. Eur Respir J 1999; 13: 38–40
  • Bucca C, Rolla G. Nebulized magnesium in asthma: the right solution for an old remedy?. Lancet 2003; 361: 2095–2096
  • Jenner R, Body R. Intravenous magnesium in COPD. Emer Med J 2004; 21(2)203
  • Saris N EL, Mervaala E, Karppanen H, Khawaja J, Lewenstam A. Magnesium: an update on physiological, clinical and analytical aspects. Clinica Chimica Acta 2000; 294: 1–26
  • Elin R J. Magnesium: The fifth but forgotten electrolyte. Am J Clin Pathol 1994; 102: 616–622
  • Ryschon T W, Rosenstein D L, Rubinov D R, Niemela J E, Elin R J, Balaban R S. Relationship between skeletal muscles intracellular ionized magnesium and measurement of blood magnesium. J Lab Clin Med 1996; 127: 207–213
  • Altura B M, Altura B T. Role of magnesium in pathophysiological processes and the clinical utility of magnesium ion selective electrodes. Scand J Clin Lab Invest Suppl 1996; 224: 211–234
  • Elin R J. Evaluating the role of ionized magnesium in laboratory and clinical practice. Advances in Magnesium Research. 1. Magnesium in Cardiology, R Smetana. John Libbey, Vienna 1995; 252–259
  • Iseri T, French J H. Magnesium: Nature's physiologic calcium blocker. Am Heart J 1984; 108: 193–189
  • Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1986; 21(97)77–89
  • American Thoracic Society. Lung function testing: selection of reference value and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202–1218
  • Pauwels R A, Buist A S, Calverley P M, Jenkins C R, Hurd S S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1256–1276
  • Wouters E FM. Local and systemic inflammation in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society 2005; 2: 26–33
  • MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001; 429(1–3)195–207
  • Repine J E, Bast A, Lankhorst I. Oxidative stress in chronic obstructive disease. Am J Resp Cri Care 1997; 156: 341–357
  • Burnett D, Hill S L, Chamba A. Neutrophils from subjects with chronic lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet 1987; 2: 1043–1046
  • Noguera A, Batle S, Miralles C, Iglesias I, Busquets X, Mec Nee W, Agusto A GN. Neutrophil response in chronic obstructive pulmonary disease. Thorax 2001; 56: 432–437
  • Noguera A, Busquets X, Salueda I, Vilaverde J M, Mac Nee W, Agusto A GN. Expression of molecules and G proteins in circulating neutrophils in chronic obstructive disease. Am J Resp Crit Care Med 1998; 158: 1664–1668
  • Cross A, Erickson R, Ellis B A, Curnutte J T. Spontaneous activation of NADPH oxidase in cell free system: unexpected multiple effects of magnesium ion concentrations. Biochem J 1999; 338: 229–233
  • Salueda J, Garcia Palmer F J, Gonzales G, Palou A, Agusto A G. The activity of cytochrom oxidaze is increased in circulating lymphocytes of patients with chronic obstructive disease, asthma and chronic arthritis. Am J Resp Crit Care Med 2000; 161: 32–35
  • Busiere F I, Mazur A, Fauquert J L, Labbe A, Rayssiguier Y, Tridon A. High magnesium concentration in vitro decrease human leukocyte activation. Magnes Res 2002; 15(1–2)43–48
  • Dominguez L J, Barbagalo M, Di Lorenzo G, Drago A, Scola S, Morici G, Caruso C. Bronchial reactivity and intracellular magnesium: a possible role for the bronchodilating effects of magnesium in asthma. Clin Sci 1998; 95: 137–142
  • Fantidis P, Cacho J R, Marin M, Jarabo R M, Solera J, Herrero E. Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks. J R Soc Med 1995; 88: 441–445
  • Rowe B, Bretzlaff J A, Bota G W, Camargo C A. Intravenous magnesium sulphate treatment for acute asthma in the emergency department: a systematic review of the literature. Ann Emer Med 2000; 36(3)181–190
  • Skorodin M S, Tenholder M F, Yetter B. Magnesium sulphate in exacerbation of chronic obstructive pulmonary disease. Archive of internal medicine 1995; 155(5)496–513
  • Rolla G, Bucca C, Bugiani M, Oliva A, Brancifore L. Hypomagnesaemia in Chronic Obstructive Lung Disease: Effect of therapy. Magnesium Trace Elem 1990; 9: 132–136
  • Kurys E, Kurys P, Kierzko R. Analysis of antioxidant enzyme activity and magnesium level in chronic obstructive pulmonary disease. Annals Universitatis Mariae Curie Lublin 2001; 42: 262–265
  • Buhl R, Farmer S G. Future direction in the pharmacologic therapy of chronic obstructive disease. Proc Amer Thoracic Soc 2005; 2: 83–93
  • Durlach J, Pages N, Bac P, Bara M, Guiet-Bara A. Beta2-mimetics and magnesium: true or false friends?. Magnes Res 2003; 16(3)218–233

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.